Medicare GLP-1 Bridge Program: What Medicare Beneficiaries Need to Know Medicare GLP-1 Bridge Program: Weight Loss Medication Coverage in 2026 Beginning July 1, 2026 , the Centers for Medicare & Medicaid Services will launch a new temporary program called the Medicare GLP-1 Bridge Program
2025 Jul;33(7):1232-1236
provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself
However, the RCT studies, case reports, and the FAERS database case all highlighted that we should be aware of co-administered neuropsychotropic drugs that may associated with SSIBs
The platform uses this information to determine whether you qualify for semaglutide or tirzepatide treatment
Depending on the response, the dose may be increased to 12.5mg for weeks 17 to 20, and then to 15mg starting from week 21